Pharmacokinetics and Safety of Fospropofol Disodium for Injection in Subjects with Hepatic Impairment Compared with Healthy Matched Controls: A Prospective Cohort Study Publication Pharmacokinetics and Safety of Fospropofol Disodium for Injection in Subjects with Hepatic Impairment Compared with Healthy Matched Controls: A Prospective Cohort Study Learn how faster fospropofol elimination but slower propofol clearance can help hepatic impairment, analysed using…CertaraOctober 17, 2025
Streamlining PK/PD reporting: A smarter approach to generating tables, figures and listings Blog Streamlining PK/PD reporting: A smarter approach to generating tables, figures and listings Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…CertaraOctober 16, 2025
PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software Live Events PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software – Scarman, Coventry, UKCertaraOctober 14, 2025
Exploring the Population Pharmacokinetic and Pharmacogenetics Characteristics of Flurbiprofen Isomers in Selective Joint Replacement Patients with Postoperative Pain Publication Exploring the Population Pharmacokinetic and Pharmacogenetics Characteristics of Flurbiprofen Isomers in Selective Joint Replacement Patients with Postoperative Pain Find out how Phoenix NLME identifies pharmacogenetic drivers of flurbiprofen enantiomer clearance and CSF distribution…CertaraOctober 9, 2025
Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects Publication Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects Explore how fed‑condition crossover study confirms bromocriptine mesylate bioequivalence and safety, analysed using Phoenix WinNonlin.CertaraSeptember 29, 2025
Pharmacokinetics, Relative Bioavailability, and Safety of the SHR0302 Oral Solution and Tablets: A Single-Center, Randomized, Open-Label, Crossover (Two-Formulation, Two-Period) Phase I Trial in Healthy Chinese Volunteers Publication Pharmacokinetics, Relative Bioavailability, and Safety of the SHR0302 Oral Solution and Tablets: A Single-Center, Randomized, Open-Label, Crossover (Two-Formulation, Two-Period) Phase I Trial in Healthy Chinese Volunteers Discover how oral solution and tablet formulations of SHR0302 show comparable bioavailability and safety in…CertaraSeptember 26, 2025
Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings On-Demand Webinar Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings Watch Certara’s webinar with Kristin Follman to discover how TFL Studio streamlines the process to…CertaraSeptember 22, 2025
ADPO: automatic-differentiation-assisted parametric optimization Publication ADPO: automatic-differentiation-assisted parametric optimization See how Automatic differentiation reduces PK/PD model runtime by up to 95% while preserving accuracy,…CertaraSeptember 22, 2025
Phoenix® Cloud: Accelerating PK Science with AI and the Cloud Brochure Phoenix® Cloud: Accelerating PK Science with AI and the Cloud Discover how Phoenix Cloud frees PK/PD teams to focus on the science.CertaraSeptember 15, 2025
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…CertaraSeptember 11, 2025